The novel therapy of the medication represents a significant development in the management of the condition. Unlike existing medications, tirzepatide targets dual pathways – the GLP-1 hormone and glucose-dependent https://tirzepatide-peptide901326.aioblogs.com/94738948/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment